Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial (vol 403, pg 1866, 2024)

被引：0
|
作者：
Ge, Z.
Kan, J.
Gao, X.
机构：
来源：
LANCET | 2024年 / 403卷 / 10439期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1854 / 1854
页数：1
相关论文
共 23 条
  • [1] Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT) a randomised, placebo-controlled, double-blind clinical trial
    Ge, Zhen
    Kan, Jing
    Gao, Xiaofei
    Raza, Afsar
    Zhang, Jun-Jie
    Mohydin, Bilal S.
    Gao, Fentang
    Shao, Yibing
    Wang, Yan
    Zeng, Hesong
    Li, Feng
    Khan, Hamid Sharif
    Mengal, Naeem
    Cong, Hongliang
    Wang, Mingliang
    Chen, Lianglong
    Wei, Yongyue
    Chen, Feng
    Stone, Gregg W.
    Chen, Shao-Liang
    LANCET, 2024, 403 (10439): : 1866 - 1878
  • [2] Ticagrelor Alone vs Ticagrelor Plus Aspirin From Month 1 to Month 12 After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes (ULTIMATE-DAPT): A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
    Chen, Shao-Liang
    Stone, Gregg
    Ge, Zhen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B30 - B30
  • [3] One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial
    Sandner, Sigrid
    Gaudino, Mario
    Redfors, Bjoern
    Angiolillo, Dominick J.
    Ben-Yehuda, Ori
    Bhatt, Deepak L.
    Fremes, Stephen E.
    Lamy, Andre
    Marano, Riccardo
    Mehran, Roxana
    Pocock, Stuart
    Rao, Sunil V.
    Spertus, John A.
    Weinsaft, Jonathan W.
    Wells, George
    Ruel, Marc
    EUROINTERVENTION, 2024, 20 (05) : E322 - +
  • [4] Ticagrelor monotherapy after ≤ 1-month DAPT vs continued DAPT in patients with acute coronary syndrome treated with percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials
    Weba, Elizabet Taylor Pimenta
    Ipacio, Alexandros Paris de Mesquita
    da Hora, David Abraham Batista
    Fukunaga, Christian Ken
    Camarotti, Maria Tereza
    Corvelo, Arthur Parke Costa
    Ferreira, Andre Luiz Carvalho
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (12)
  • [5] Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial
    Weisz, Giora
    Genereux, Philippe
    Iniguez, Andres
    Zurakowski, Aleksander
    Shechter, Michael
    Alexander, Karen P.
    Dressler, Ovidiu
    Osmukhina, Anna
    James, Stefan
    Ohman, E. Magnus
    Ben-Yehuda, Ori
    Farzaneh-Far, Ramin
    Stone, Gregg W.
    LANCET, 2016, 387 (10014): : 136 - 145
  • [6] Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial (vol 391, pg 205, 2017)
    Connolly, S. J.
    Eikelboom, J. W.
    LANCET, 2018, 391 (10117): : 204 - 204
  • [7] Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial
    Farshidi, Hossein
    Bijani, Badri
    Sobhani, Seyed Alireza
    Dastsouz, Farideh
    Abbaszadeh, Shahin
    TRIALS, 2025, 26 (01)
  • [8] Coronary microcirculation in diabetic patients assessed by magnetic resonance imaging: double-blind, placebo-controlled, randomised trial of simvastatin versus simvastatin plus niacin over 12 months
    Schmermund, A.
    Magedanz, A.
    Lehmann, N.
    Gottwald-Hostalek, U.
    Probst, K.
    Schmidt, M.
    Nowak, B.
    Voigtlaender, T.
    EUROPEAN HEART JOURNAL, 2010, 31 : 785 - 785
  • [9] Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial
    Amit, Guy
    Cafri, Carlos
    Yaroslavtsev, Sergei
    Fuchs, Shmuel
    Paltiel, Ora
    Abu-Ful, Akram
    Weinstein, Jean M.
    Wolak, Arik
    Ilia, Reuben
    Zahger, Doran
    AMERICAN HEART JOURNAL, 2006, 152 (05) : 887.e9 - 887.e14
  • [10] RETRACTION: Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial (Retraction of Vol 142, Pg 1799, 2020)
    Willemsen, L. M.
    Janssen, P. W. A.
    Peper, J.
    Soliman-Hamad, M. A.
    van Straten, A. H. M.
    Klein, P.
    Hackeng, C. M.
    Sonker, U.
    Bekker, M. W. A.
    von Birgelen, C.
    Brouwer, M. A.
    van der Harst, P.
    Vlot, E. A.
    Deneer, V. H. M.
    Yin, Chan Pin D. R. P. P.
    Gimbel, M. E.
    Beukema, K. F.
    Daeter, E. G.
    Jelder, J. C.
    Tijssen, J. G. P.
    Rensing, B. J. W. M.
    van Es, H. W.
    Swaans, M. J.
    ten Berg, J. M.
    CIRCULATION, 2021, 144 (02) : E36 - E36
123